BREAST CANCER REPORT 2017 4
EXECUTIVE SUMMARY
Background and context
Breast cancer is the most common cancer in women worldwide. Approximately 1.7 million
new cases were recorded globally in 2012, accounting for 25 per cent of all new cases of
cancer in women. It is the fth most common cause of death from cancer in women [2].
Breast cancer risk doubles each decade until the menopause, after which the increase
slows [3]. However, breast cancer is more common after the menopause. The highest
incidence is in Northern America and the lowest incidence is in Middle Africa and Eastern
Asia. In 2012, the rate of new cases of breast cancer in Northern America was more
than double that in Africa [2].
Survival rates for breast cancer vary worldwide, but in general rates have improved.
This is because breast cancer is diagnosed at an earlier and localised stage in nations
where populations have access to medical care and because of progressive improvement
in treatment strategies. In many countries with advanced medical care, the ve-year
survival rate of early stage breast cancers is 80-90 per cent, falling to 24 per cent
for breast cancers diagnosed at a more advanced stage, indicating a critical need for
improved treatment of metastatic disease.
Breast cancer is a heterogeneous disease, but most breast cancer subtypes are
hormone-related. The natural history of the disease differs between those diagnosed
before and after the menopause, which may be due to different kinds of tumour and
possibly different effects of nutritional factors on hormones depending on menopausal
status. Breast cancers have long been classied by their hormone receptor type; for
example, to what extent the cancer cells have receptors for the hormones oestrogen and
progesterone, which can predict the behaviour of the cancer and response to therapy.
Breast cancer cells that have oestrogen receptors are referred to as oestrogen-positive
(ER+), while those containing progesterone receptors are called progesterone-positive
(PR+) cancers. Hormone receptor positive cancers are the most common subtypes
of breast cancer at the time of diagnosis and have a relatively better prognosis than
hormone receptor negative cancers, which are likely to be of higher pathological grade
and can be more difcult to treat [4]. Many epidemiologic studies have classied breast
cancer cases by menopausal status at time of diagnosis, and therefore in this report we
chose to highlight associations between diet, weight and physical activity separately in
premenopausal and postmenopausal breast cancer, where possible.
In this report from our Continuous Update Project (CUP) – the world’s largest source
of scientic research on cancer prevention and survivorship through diet, weight and
physical activity – we analyse global research on how certain lifestyle factors affect the
risk of developing breast cancer. This includes new studies as well as those included in
our 2007 Second Expert Report, Food, Nutrition, Physical Activity, and the Prevention of
Cancer: a Global Perspective [1].